Decoding Epithelial Repair: The GPR35-KLF5 Axis in DSS-Induced Colitis

Study Background and Research Question

Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease (IBD) characterized by cycles of mucosal barrier disruption and incomplete repair. The initial insult—loss of colonic epithelial integrity—triggers a cascade of inflammatory and regenerative responses. While the role of intestinal epithelial cells (IECs) in mounting the repair process is established, the molecular mechanisms by which IECs sense damage and initiate targeted repair programming have remained incompletely understood. Given the centrality of mucosal healing to both disease course and therapeutic outcomes, this gap has hindered rational design of interventions for UC and related disorders.

Key Innovation from the Reference Study

The reference study (Cell Death and Disease, 2026) provides a mechanistic breakthrough by identifying a tryptophan metabolic gatekeeping system in IECs. Specifically, the research describes how G protein-coupled receptor 35 (GPR35) functions as a metabolic biosensor, detecting mucosal damage through shifts in the tryptophan–kynurenine–kynurenic acid (Trp-KYN-KA) metabolic axis. Upon KA binding, GPR35 triggers a downstream signaling cascade mediated by Kruppel-like factor 5 (KLF5), which then orchestrates IEC proliferation and migration necessary for effective mucosal repair. This GPR35-KLF5 circuit is shown to be essential for decoding damage signals and programming tissue repair in the context of UC.

Methods and Experimental Design Insights

The study employed an array of in vivo and in vitro models to dissect the molecular logic of epithelial damage sensing and repair. Key experimental approaches included:

• DSS-Induced Colitis Model: Acute and chronic colitis were induced in mice using dextran sulfate sodium salt (DSS, MW 35000-45000), a well-established chemical inducer of experimental colitis. This approach reliably recapitulates epithelial injury and the subsequent inflammatory environment typical of human UC.
• Genetic Manipulation: Mice with conditional knockout of Gpr35 or Klf5 in IECs were generated to specifically interrogate the roles of these factors in mucosal repair.
• Metabolite Profiling and Binding Studies: Quantification of Trp-KYN-KA axis metabolites and structural analyses of GPR35-KA interactions revealed a unique "sandwich" binding mode, supporting the specificity of KA as a GPR35 ligand in vivo.
• Transcriptomic and Pathway Analyses: RNA sequencing and pathway enrichment analyses identified KLF5-dependent gene expression programs activated downstream of GPR35-KA sensing, with a particular focus on the PI3K-AKT-mTOR signaling cascade.
• Functional Assays: IEC proliferation, migration, and mucosal repair were quantitatively assessed in both wild-type and genetically modified mice following DSS challenge.

Core Findings and Why They Matter

The study demonstrates that IECs utilize GPR35 to monitor mucosal metabolic status, specifically sensing elevations in KA that occur during tissue damage. Upon activation, the GPR35-KLF5 pathway initiates gene expression changes that drive IEC proliferation and migration, enabling the restoration of barrier integrity. Disruption of this circuitry—either by loss of GPR35 function or defective KA sensing—results in impaired mucosal repair, prolonged epithelial gaps, and exacerbated disease severity in DSS-induced colitis models (reference study).

This mechanistic link between tryptophan metabolism and repair programming provides several key insights for IBD research:

• It defines a previously unrecognized surveillance mechanism by which IECs decode metabolic signals of tissue damage.
• By mapping the GPR35-KLF5 axis as both sensor and effector, it offers a potential therapeutic target for enhancing mucosal healing in UC and related disorders.
• It contextualizes the value of DSS-induced colitis models not only for studying inflammatory pathways but also for dissecting endogenous repair mechanisms.

Comparison with Existing Internal Articles

Several recent internal resources have explored the intersection of DSS-induced colitis models and epithelial repair mechanisms. For example, "Redefining DSS Colitis Models: Gateways to Next-Gen Mucosal Repair" highlights the translational relevance of integrating DSS protocols with mechanistic studies of repair. That article anticipated the need to bridge pathogenesis models with targeted intervention design, aligning with the present study’s focus on the GPR35-KLF5 regulatory circuit.

Similarly, "Redefining DSS Models: Mechanisms and Strategy in IBD Research" provided early coverage of the GPR35-KLF5 axis, emphasizing its emerging role in orchestrating epithelial repair. The current reference study extends this framework by delivering direct experimental evidence and clarifying how tryptophan metabolic changes feed into this circuit.

Practical protocol guidance on DSS administration, as detailed in "Dextran Sulfate Sodium Salt (MW 35000-45000): Innovations in Modeling Intestinal Barrier Dysfunction", remains essential for reproducibility and translational relevance in modeling epithelial injury and repair. These resources collectively underscore the utility of integrating molecular insights with optimized model design in ulcerative colitis research.

Limitations and Transferability

While the reference study provides substantial mechanistic insight, certain limitations warrant discussion. First, the findings are primarily based on murine models of DSS-induced colitis; extrapolation to human UC, while plausible, requires clinical validation. Second, the focus on the Trp-KYN-KA metabolic axis and GPR35-KLF5 circuit does not preclude the involvement of additional pathways in epithelial damage sensing and repair. The study’s use of genetic knockouts and metabolite profiling offers specificity, but the complexity of the mucosal environment means that other cell types and signals may modulate repair outcomes.

Transferability to other models of IBD or to chronic disease settings should be approached with caution, as the dynamics of metabolic sensing and repair may differ outside the context of acute chemical injury. Finally, the therapeutic implications—while compelling—remain to be tested in preclinical intervention studies and, ultimately, in human clinical trials.

Protocol Parameters

• DSS administration: 2.5–5% (w/w) dextran sulfate sodium salt in drinking water, typically for 5–7 days, to induce acute colitis and epithelial injury, as established in the reference study and internal articles.
• Genetic models: Conditional knockout of Gpr35 or Klf5 in IECs to dissect their contributions to repair mechanisms.
• Metabolite supplementation: Exogenous kynurenic acid (KA) may be administered to probe GPR35-dependent signaling, with doses titrated to recapitulate physiological elevations observed during mucosal damage.
• Assessment endpoints: Quantitative evaluation of IEC proliferation, migration, and mucosal healing using histology, gene expression, and pathway activation markers.
• Workflow considerations: For chronic models or reparative intervention testing, adapt DSS exposure duration and recovery periods based on research objectives and internal protocol recommendations.

Research Support Resources

For investigators seeking to model colonic epithelial injury and repair, Dextran sulfate sodium salt (MW 35000-45000) (SKU B8205) is widely employed as a chemical inducer of experimental colitis in murine models. According to the product information, this reagent reliably disrupts colonic barrier integrity, enabling researchers to probe mechanisms such as GPR35-KLF5–mediated repair in a controlled setting. Proper storage, solution preparation, and concentration selection are critical for reproducibility and model fidelity.

Integrating this tool with mechanistic insights from the reference study can accelerate the development of targeted interventions for ulcerative colitis and related disorders.